Science Explorer Interactive view Map
Company · Hyderabad · India

IBC Pharmaceuticals (India)

ibcpharma.comROR OpenAlex
Research works
31
▲ 28% vs 2013–17
Citations
578
18.8 per fractional work
Top-10% rate
10.7%
record average 16.5%
Open access
42%
world 28%

Not ranked overall: IBC Pharmaceuticals (India) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.30× its world share, 0 worksBiochemistry, Geneti…Neuroscience: 2.20× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 38.35× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 4.55× its world share, 0 worksChemical EngineeringChemistry: 8.61× its world share, 1 worksChemistryEnvironmental Science: 0.64× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.46× its world share, 0 worksMaterials ScienceMedicine: 3.01× its world share, 2 worksMedicinePsychology: 1.17× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 38.4×. Every wedge is a field page.

Which keywords describe research at IBC Pharmaceuticals (India)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibody, Monoclonal Antibodies, Therapeutic Antibodies, Biopharmaceutical Production, Mammalian Cells, Recombinant Protein and Epidemiology.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Glycosylation3▲ 42×3 topics
  2. Epidemiology2▲ 2.0×12 topics
  3. Inflammation2▲ 2.6×8 topics
  4. Monoclonal Antibody2▲ 85×2 topics
  5. Monoclonal Antibodies2▲ 35×2 topics
  6. Therapeutic Antibodies2▲ 39×2 topics
  7. Biopharmaceutical Production2▲ 62×2 topics
  8. Mammalian Cells1▲ 110×1 topic
  9. Recombinant Protein1▲ 110×1 topic
  10. Antibody Engineering1▲ 40×1 topic
  11. Fc Receptors1▲ 40×1 topic
  12. Gene Therapy1▲ 14×3 topics
  13. Oxidative Stress1▲ 2.1×6 topics
  14. Risk Assessment1▲ 6.5×3 topics
  15. Targeted Therapy1▲ 18×4 topics
  16. Cancer1▲ 2.6×5 topics
  17. Analytics1▲ 61×1 topic
  18. Big Data1▲ 6.0×1 topic
  19. Chemical Management1▲ 326×1 topic
  20. Genomic Integration1▲ 31×2 topics
  21. Green Chemistry1▲ 11×5 topics
  22. Laboratory Safety1▲ 326×1 topic
  23. PET Imaging1▲ 16×2 topics

Which research topics does IBC Pharmaceuticals (India) publish most on?

By volume in 2022–2025: Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, HER2/EGFR in Cancer Research and Advanced Drug Delivery Systems.

Chronic Myeloid Leukemia Treatments: 0 fractional worksChronic Lymphocytic Leukemia Research: 0 fractional worksHER2/EGFR in Cancer Rese…0HER2/EGFR in Cancer Research: 0 fractional worksAdvanced Drug Delivery S…0Advanced Drug Delivery Systems: 0 fractional worksLiver Disease Diagnosis and Treatment: 0 fractional worksCannabis and Cannabinoid Research: 0 fractional worksSynthesis and Reactivity…0Synthesis and Reactivity of Sulfur-Containing Compounds: 0 fractional worksPhosphorus compounds and reactions: 0 fractional worksAlcohol Consumption and Health Effects: 0 fractional worksOcular Surface and Conta…0Ocular Surface and Contact Lens: 0 fractional works
HematologyGeneticsOncologyPharmaceutical Science5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Chronic Myeloid Leukemia Treatments Hematology 0 works
  2. 2 Chronic Lymphocytic Leukemia Research Genetics 0 works
  3. 3 HER2/EGFR in Cancer Research Oncology 0 works
  4. 4 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
  5. 5 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  6. 6 Cannabis and Cannabinoid Research Pharmacology 0 works
  7. 7 Synthesis and Reactivity of Sulfur-Containing Compounds Organic Chemistry 0 works
  8. 8 Phosphorus compounds and reactions Organic Chemistry 0 works
  9. 9 Alcohol Consumption and Health Effects Pathology and Forensic Medicine 0 works
  10. 10 Ocular Surface and Contact Lens Public Health, Environmental and Occupational Health 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.5%not open58.5%

World: 28% of research is openly available.

with international co-authors36.2%domestic only63.8%

World: 19% is written across borders.

How has IBC Pharmaceuticals (India)'s research output changed?

Output in 2018–2022 was 28% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Hyderabad

All research institutions in Hyderabad

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.